Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Denmark
  • Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Denmark France
  • A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

    Not yet recruiting

    1 1 1
    France Germany Greece Italy Spain Sweden
  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    1 1 1 1
    Bulgaria Croatia Czechia France Hungary Ireland +4
  • A study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors

    Not recruiting

    1 1 1
    Austria Belgium France Germany Italy Spain
  • A study of long-term safety and effectiveness of denecimig in people with haemophilia A with or without inhibitors

    Not recruiting

    1 1 1
    Austria Belgium Bulgaria Denmark France Germany +10
  • Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium France Germany
  • Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Norway Spain Sweden
  • Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark Estonia France Germany Hungary Italy +5
  • Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Italy Norway